# Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence

> **NCT02120365** · PHASE1,PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 22 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Perampanel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02120365
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-02-16
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-08-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120365, "Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02120365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*